Statins in the Treatment of Breast Cancer Survivors

Because of the improvements in survival rates, patients with breast cancer are now more likely to die from cardiovascular disease than from cancer. In the latest Cardiology Center of Excellence edition of Ochsner Journal, Shum and colleagues explore the management of cardiovascular risk in women with breast cancer.

The authors retrospectively compared the management of cardiovascular risk of women treated at a cardio-oncology clinic to that of women seen at an obstetrics and gynecology clinic. The study focused particularly on the appropriate prescription of statins to women at high risk of cardiovascular disease according to the American College of Cardiology/American Heart Association guidelines. Women in both clinics had a similar level of cardiovascular risk; however, significantly fewer women in the cardio-oncology clinic were prescribed statins in accordance with these guidelines.

Read more about this study’s important findings here.